海外の治験の状況「1」での検索結果
27件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not Available
- Safety and Efficacy Study of Daptomycin in Pediatric Participants (1 to 17 Years-old) With Skin and Skin Structure Infections
- Complicated skin and skin structure infections (cSSSI) caused by Gram-positive pathogens;Therapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]
- India, Panama, United States
- 2015-06-29
Not Available
- A fibrinogen concentrate study in paediatric patients with inherited fibrinogen deficiency
- Afibrinogenaemia or severe hypofibrinogenaemia MedDRA version: 16.1 Level: LLT Classification code 10052651 Term: Afibrinogenaemia System Organ Class: 100000004850 MedDRA version: 16.1 Level: PT Classification code 10051125 Term: Hypofibrinogenaemia System Organ Class: 10005329 - Blood and lymphatic system disorders ;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
- Lebanon, Morocco, Turkey
- 2014-04-04
Not Available
- A study to compare the immunogenicity of GSK Biologicals' 10Pn-PD-DiT 4-dose presentation to the licensed 1-dose Synflorix™ (10Pn-PD-DiT) vaccine when co-administered with DTPw-combination vaccine in healthy infants.
- Infections, Pneumococcal;Therapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]
- Bangladesh
- 2015-05-05
Not Available
- A Clinical Tial to evaluate the Efficacy and Safety of Dasiglucagon for the Treatment of Children with Congenital Hyperinsulinism
- Children with congenital hyperinsulinism MedDRA version: 20.0 Level: PT Classification code 10061211 Term: Hyperinsulinism System Organ Class: 10027433 - Metabolism and nutrition disorders ;Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- France, Germany, Israel, United Kingdom, United States
- 2018-09-03
Not Available
- A study to determine if A4250 is safe and can be used to treat children with Progressive Familial Intrahepatic Cholestasis Types 1 and 2.
- Progressive Familial Intrahepatic Cholestasis Types 1 and 2 MedDRA version: 20.0 Level: PT Classification code 10076033 Term: Progressive familial intrahepatic cholestasis System Organ Class: 10010331 - Congenital, familial and genetic disorders ;Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Australia, Belgium, Canada, France, Germany, Israel, Italy, Netherlands, Poland, Saudi Arabia, Spain, Sweden, Turkey, United Kingdom, United States
- 2018-01-29
Not Available
- A study to determine the long term effect and safety of A4250 in treatment of children with Progressive Familial Intrahepatic Cholestasis Types 1 and 2.
- Progressive Familial Intrahepatic Cholestasis Types 1 and 2 MedDRA version: 20.0 Level: PT Classification code 10076033 Term: Progressive familial intrahepatic cholestasis System Organ Class: 10010331 - Congenital, familial and genetic disorders ;Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Australia, Belgium, Canada, France, Germany, Israel, Italy, Netherlands, Poland, Saudi Arabia, Spain, Sweden, Turkey, United Kingdom, United States
- 2018-06-06
Not Available
- Efficacy and Safety of RAD001 in Treating Plexiform Neurofibromas (PN) Associated With Neurofibromatosis (NF1)
- Plexiform Neurofibroma Associated With Neurofibromatosis Type 1;Therapeutic area: Diseases [C] - Cancer [C04]
- Israel
- 2016-05-12
Not Available
- A phase 1/2 study of the investigational treatment LOXO-195 in adults and minors that have a previously treated cancer with a change in a gene called NTRK.
- NTRK fusion cancers previously treated with a TRK inhibitor MedDRA version: 20.0 Level: LLT Classification code 10049516 Term: Malignant tumor System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 20.0 Level: PT Classification code 10007958 Term: Central nervous system neoplasm System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Denmark, France, Germany, Italy, Korea, Republic of, Singapore, Spain, United States
- 2018-01-23
Not Available
- A Phase 3 Study of an Investigational Drug, Lumasiran (ALN-GO1) with an Extended Dosing Period in Children and Adults with Primary Hyperoxaluria Type 1 Disease
- Primary Hyperoxaluria Type 1 (PH1) MedDRA version: 20.1 Level: PT Classification code 10020703 Term: Hyperoxaluria System Organ Class: 10038359 - Renal and urinary disorders ;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
- France, Germany, Israel, Japan, Jordan, Netherlands, Switzerland, United Arab Emirates, United States
- 2018-09-11
Not Available
- A controlled clinical trial to look at the effects of treatment with rufinamide on the body, thought process development and its safety in children aged 1 to 4 years with poorly controlled Lennox Gastaut Syndrome.
- Lennox Gastaut Syndrome MedDRA version: 13.1 Level: PT Classification code 10048816 Term: Lennox-Gastaut syndrome System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- France, Greece, India, Italy, United States
- 2011-05-19
